Development of Sarcoidosis during Etanercept Therapy
Author:
Affiliation:
1. Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center
2. Division of Pathology, Saitama Cardiovascular and Respiratory Center
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/47/11/47_11_1021/_pdf
Reference21 articles.
1. 1. Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 30: 1864-1867, 2003.
2. 2. Hobbs K. Chronic sarcoid artheitis treated with intraarticular etanercept [letter]. Arthritis Rheum 52: 987-988, 2005.
3. 3. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16: 149-173, 1999.
4. 4. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124: 177-185, 2003.
5. 5. Phillips K, Weinblatt M. Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 53: 618-620, 2005.
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Pathogenesis and Progression of Sarcoidosis from the Standpoint of Tuberculosis;Integrated Science;2023
2. Cutaneous sarcoidosis;Sarcoidosis;2022-03
3. Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort;Rheumatology and Therapy;2022-02-08
4. Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review;BMC Gastroenterology;2021-10-12
5. Une tularémie mimant un lymphome;La Revue de Médecine Interne;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3